Interestingly enough, in an effort to cut costs, and possibly create a new pharmaceutical-biotech ecosystem that was being outsourced, the various companies involved created a tier system for those ecosystems. The first tier concerned services, materials and of course knowledge that directly impacted the productivity and value of drug development. The second tier as comprised of those suppliers of test animals, instrumentation systems, and reagents that were absolutely required in providing new drugs. The two-tier system did not work and was set aside when drug companies allied with strong product pipelines instead.
College graduates who wish to take their positions with pharmacy jobs that fit in the pharmaceutical-biotech ecosystem need to understand the value shifts as described in the above paragraph You see, you not only need to build skills that will be needed in that ecosystem, but you also need to increase your awareness of companies and businesses that will fit in your particular goals and aspirations.
Then, in seeking various pharmacy jobs, also realize the tremendous changes that have taken place in pharmaceutical-biotech systems. For instance an expansive assortment of proteomics and genomics technologies are progressively more often integrated into up-and-coming research fields encompassing chemical biology, chemical genetics, chemogenomics, pharmacoproteomics as well as pharmacogenomics.
Thus with such advancements in each field, it stands to reason that you no longer have a limited choice of where pharmaceutical jobs are located, such as long-term care facilities, various pharmaceutical corporations and also with biotechnological corporations, hospitals and of course retail pharmacies, but now the field has opened up tremendously allowing you to specialize in the above research fields that can take you much further economically as well as advancing you through the medical field.
Rarely are pharmacist jobs threatened, in fact it’s just the reverse. In making biotechnology drugs, they are made using living cells and thus require longer times to test them, much less develop them. At the moment there are some serious problems facing the ecosystem of pharmaceutical-biotech systems. Both are somber threats. The first is patent legislation that threatens various biotechnology patent protections Secondly is the amount of time that biotechnology companies can be expected to receive before other companies are allowed to duplicate drugs.
On the other hand, manufacturers of robotics and laboratory automation equipment, cite that because it costs so much to live in California where the strongest and largest biotech regions are located in the United States, many of the pharmaceutical-biotech ecosystem companies are moving to different and lower-cost regions of the United States. This in turn has created newer jobs in not only pharmaceutical jobs, but in pharmaceutical-biotech jobs too.
It has been said over and over again that pharmaceutical-biotech jobs will always appeal to those who wish to move into ''smart growth'' jobs. These jobs are definitely good fits for those people. The actual potential for growth is almost unable to be measured, and they go way beyond any other pharmaceutical jobs that are in the offering at the moment. Of course as mentioned there are technical as well as various regulatory challenges about, and thus risks remain, however, one must remember that biotech is no longer being dreamt about, both biotech products and the revenue streams it can bring about are definitely real.
